Cargando…
Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
We report on an impressive case of a previously healthy 47-year-old female Caucasian SARS-CoV-2 positive patient who died within 48 h after initial cardiac symptoms. Autopsy revealed necrotizing myocarditis and extensive microthrombosis as the cause of death. The interesting feature of this case is...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358395/ https://www.ncbi.nlm.nih.gov/pubmed/34395562 http://dx.doi.org/10.3389/fcvm.2021.695010 |
_version_ | 1783737330727649280 |
---|---|
author | Menter, Thomas Cueni, Nadine Gebhard, Eva Caroline Tzankov, Alexandar |
author_facet | Menter, Thomas Cueni, Nadine Gebhard, Eva Caroline Tzankov, Alexandar |
author_sort | Menter, Thomas |
collection | PubMed |
description | We report on an impressive case of a previously healthy 47-year-old female Caucasian SARS-CoV-2 positive patient who died within 48 h after initial cardiac symptoms. Autopsy revealed necrotizing myocarditis and extensive microthrombosis as the cause of death. The interesting feature of this case is the combination of both myocarditis and extensive localized microthrombosis of cardiac capillaries. Microthrombosis was not present in other organs, and the patient did not show typical features of diffuse alveolar damage in the lungs. Taken together, our morphologic findings illustrate the angiocentric, microangiopathic, thromboinflammatory disease with significant thrombotic diathesis prevalent in COVID-19, which has been previously described in the literature, likely warranting thromboprophylaxis even in oligosymptomatic circumstances. This case also delineates several potential etiologies for microthrombosis, i.e., inflammatory reactions and primary hypercoagulative states. Further systematic analyses on risk stratification for receipt of prophylactic anticoagulation in COVID-19 are urgently required. |
format | Online Article Text |
id | pubmed-8358395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83583952021-08-13 Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient Menter, Thomas Cueni, Nadine Gebhard, Eva Caroline Tzankov, Alexandar Front Cardiovasc Med Cardiovascular Medicine We report on an impressive case of a previously healthy 47-year-old female Caucasian SARS-CoV-2 positive patient who died within 48 h after initial cardiac symptoms. Autopsy revealed necrotizing myocarditis and extensive microthrombosis as the cause of death. The interesting feature of this case is the combination of both myocarditis and extensive localized microthrombosis of cardiac capillaries. Microthrombosis was not present in other organs, and the patient did not show typical features of diffuse alveolar damage in the lungs. Taken together, our morphologic findings illustrate the angiocentric, microangiopathic, thromboinflammatory disease with significant thrombotic diathesis prevalent in COVID-19, which has been previously described in the literature, likely warranting thromboprophylaxis even in oligosymptomatic circumstances. This case also delineates several potential etiologies for microthrombosis, i.e., inflammatory reactions and primary hypercoagulative states. Further systematic analyses on risk stratification for receipt of prophylactic anticoagulation in COVID-19 are urgently required. Frontiers Media S.A. 2021-07-29 /pmc/articles/PMC8358395/ /pubmed/34395562 http://dx.doi.org/10.3389/fcvm.2021.695010 Text en Copyright © 2021 Menter, Cueni, Gebhard and Tzankov. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Menter, Thomas Cueni, Nadine Gebhard, Eva Caroline Tzankov, Alexandar Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient |
title | Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient |
title_full | Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient |
title_fullStr | Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient |
title_full_unstemmed | Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient |
title_short | Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient |
title_sort | case report: co-occurrence of myocarditis and thrombotic microangiopathy limited to the heart in a covid-19 patient |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358395/ https://www.ncbi.nlm.nih.gov/pubmed/34395562 http://dx.doi.org/10.3389/fcvm.2021.695010 |
work_keys_str_mv | AT menterthomas casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient AT cueninadine casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient AT gebhardevacaroline casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient AT tzankovalexandar casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient |